骨髓瘤-话题@MedSci

#骨髓瘤#

4篇内容 | 2042人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2225872, encodeId=b87922258e228, content=<a href='/topic/show?id=970e659640a' target=_blank style='color:#2F92EE;'>#淋巴瘤#</a> <a href='/topic/show?id=793a101990ac' target=_blank style='color:#2F92EE;'>#骨髓瘤#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=【CCR】5517例淋巴瘤和骨髓瘤CAR-T治疗后的第二肿瘤：系统回顾和meta分析, objectType=article, longId=843096, objectId=a2d384309694, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240725/1721876888294_92910.jpg, objectUrl=/article/show_article.do?id=a2d384309694, replyNumber=0, likeNumber=75, createdTime=2024-09-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a2d384309694, moduleTitle=【CCR】5517例淋巴瘤和骨髓瘤CAR-T治疗后的第二肿瘤：系统回顾和meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d384309694)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2217063, encodeId=6afb221e063a1, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a> <a href='/topic/show?id=793a101990ac' target=_blank style='color:#2F92EE;'>#骨髓瘤#</a>, objectTitle=Blood Cancer J | 长期使用唑来膦酸治疗骨髓瘤可显著降低骨病进展风险, objectType=article, longId=836253, objectId=0f56836253ed, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240726/1721958074344_92910.png, objectUrl=/article/show_article.do?id=0f56836253ed, replyNumber=0, likeNumber=62, createdTime=2024-07-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0f56836253ed, moduleTitle=Blood Cancer J | 长期使用唑来膦酸治疗骨髓瘤可显著降低骨病进展风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f56836253ed)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2210474, encodeId=da5a22104e4cd, content=<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>干预可恢复心脏功能而不影响<a href='/topic/show?id=ff1c3654ebf' target=_blank style='color:#2F92EE;'>#卡非佐米#</a>疗效<a href='/topic/show?id=793a101990ac' target=_blank style='color:#2F92EE;'>#骨髓瘤#</a>这个研究实用!! , objectTitle=二甲双胍新用途？或将成为卡非佐米相关CVAE的有效干预手段, objectType=article, longId=829857, objectId=556a82985e17, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240612/1718188780149_1614372.png, objectUrl=/article/show_article.do?id=556a82985e17, replyNumber=0, likeNumber=77, createdTime=2024-06-18, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=556a82985e17, moduleTitle=二甲双胍新用途？或将成为卡非佐米相关CVAE的有效干预手段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=556a82985e17)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2209083, encodeId=95ec220908395, content=<a href='/topic/show?id=793a101990ac' target=_blank style='color:#2F92EE;'>#骨髓瘤#</a> <a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a> <a href='/topic/show?id=92801152391b' target=_blank style='color:#2F92EE;'>#Belantamab mafodotin#</a>, objectTitle=【NEJM】Belantamab Mafodotin联合方案治疗RRMM的两项重磅研究, objectType=article, longId=829311, objectId=3205829311ee, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240609/1717906315398_5579292.jpg, objectUrl=/article/show_article.do?id=3205829311ee, replyNumber=0, likeNumber=103, createdTime=2024-06-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3205829311ee, moduleTitle=【NEJM】Belantamab Mafodotin联合方案治疗RRMM的两项重磅研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3205829311ee)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2202029, encodeId=6b5c220202900, content=<a href='/topic/show?id=793a101990ac' target=_blank style='color:#2F92EE;'>#骨髓瘤#</a> <a href='/topic/show?id=0dc129665f7' target=_blank style='color:#2F92EE;'>#全身MRI#</a>, objectTitle=Radiology：骨髓瘤的半定量全身MRI评分系统, objectType=article, longId=824576, objectId=57ea8245e647, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696890609715_4754896.jpeg, objectUrl=/article/show_article.do?id=57ea8245e647, replyNumber=0, likeNumber=79, createdTime=2024-05-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=57ea8245e647, moduleTitle=Radiology：骨髓瘤的半定量全身MRI评分系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57ea8245e647)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2191979, encodeId=ab1821919e934, content=<a href='/topic/show?id=cce030e1225' target=_blank style='color:#2F92EE;'>#冒烟型骨髓瘤#</a> <a href='/topic/show?id=793a101990ac' target=_blank style='color:#2F92EE;'>#骨髓瘤#</a>, objectTitle=Blood：冒烟型骨髓瘤是否应该治疗？, objectType=article, longId=816247, objectId=1f3581624e10, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240305/119dbbbac86e4747bea846e62a6e2079-avkegiAh3PBj.jpg, objectUrl=/article/show_article.do?id=1f3581624e10, replyNumber=0, likeNumber=87, createdTime=2024-03-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=1f3581624e10, moduleTitle=Blood：冒烟型骨髓瘤是否应该治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f3581624e10)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2187451, encodeId=0cd4218e451e6, content=<a href='/topic/show?id=793a101990ac' target=_blank style='color:#2F92EE;'>#骨髓瘤#</a> <a href='/topic/show?id=75948599ec3' target=_blank style='color:#2F92EE;'>#自体干细胞移植#</a> <a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a> <a href='/topic/show?id=f509284024' target=_blank style='color:#2F92EE;'>#ASCT#</a>, objectTitle=【BMT】MRD是一线移植后复发的MM的预后因素, objectType=article, longId=812876, objectId=a1888128e6b5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-staff-meeting-GXNVP9J.jpg, objectUrl=/article/show_article.do?id=a1888128e6b5, replyNumber=0, likeNumber=108, createdTime=2024-02-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=a1888128e6b5, moduleTitle=【BMT】MRD是一线移植后复发的MM的预后因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1888128e6b5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2121879, encodeId=348421218e91e, content=此外与<a href='/topic/show?id=518761566e4' target=_blank style='color:#2F92EE;'>#来那度胺#</a>或<a href='/topic/show?id=c34d64e47d1' target=_blank style='color:#2F92EE;'>#泊马度胺#</a>相比，<a href='/topic/show?id=368d105e1469' target=_blank style='color:#2F92EE;'>#iberdomide#</a>在结合<a href='/topic/show?id=e75c44989f' target=_blank style='color:#2F92EE;'>#Cereblon#</a>中显示出更高的亲和力，可导致靶蛋白（包括转录因子 Ikaros 和Aiolos）强效降解，从而转化为更强效的抗<a href='/topic/show?id=793a101990ac' target=_blank style='color:#2F92EE;'>#骨髓瘤#</a>和免疫调节作用。, objectTitle=Lancet Haematol：Iberdomide治疗重度预处理多发性骨髓瘤结果，未来新治疗基石？, objectType=article, longId=743774, objectId=1037e4377463, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20221009/5f4271881054417b8c087eee008824de.jpg, objectUrl=/article/show_article.do?id=1037e4377463, replyNumber=0, likeNumber=147, createdTime=2023-03-26, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1037e4377463, moduleTitle=Lancet Haematol：Iberdomide治疗重度预处理多发性骨髓瘤结果，未来新治疗基石？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1037e4377463)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=799796, encodeId=4fe4e9979619, content=<a href='/topic/show?id=793a101990ac' target=_blank style='color:#2F92EE;'>#骨髓瘤#</a>骨髓瘤的进展非常迅速，好多大牛有讲座。, objectTitle=Post-ASCO 2020骨髓瘤的研究进展, objectType=video, longId=4489, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://medsci-video.oss-cn-shanghai.aliyuncs.com/upload/content/day_200615/big/202006151351298603.PNG, objectUrl=null, replyNumber=1, likeNumber=131, createdTime=2020-06-25, rootId=0, userName=mswert122, userId=2a791737770, projectId=1, avatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85346244892a1, moduleTitle=Post-ASCO 2020骨髓瘤的研究进展, moduleType=video, hrefUrl=)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

骨髓瘤

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#淋巴瘤# #骨髓瘤# #CAR-T#

【CCR】5517例淋巴瘤和骨髓瘤CAR-T治疗后的第二肿瘤：系统回顾和meta分析

2024-09-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#唑来膦酸# #骨髓瘤#

Blood Cancer J | 长期使用唑来膦酸治疗骨髓瘤可显著降低骨病进展风险

2024-07-27发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

#二甲双胍#干预可恢复心脏功能而不影响#卡非佐米#疗效#骨髓瘤#这个研究实用!!

二甲双胍新用途？或将成为卡非佐米相关CVAE的有效干预手段

2024-06-18发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#骨髓瘤# #治疗效果# #Belantamab mafodotin#

【NEJM】Belantamab Mafodotin联合方案治疗RRMM的两项重磅研究

2024-06-09发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#骨髓瘤# #全身MRI#

Radiology：骨髓瘤的半定量全身MRI评分系统

2024-05-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#冒烟型骨髓瘤# #骨髓瘤#

Blood：冒烟型骨髓瘤是否应该治疗？

2024-03-08发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#骨髓瘤# #自体干细胞移植# #MRD# #ASCT#

【BMT】MRD是一线移植后复发的MM的预后因素

2024-02-15发表于陕西省

侠胆医心 (审核中...)

前往app查看评论内容

此外与#来那度胺#或#泊马度胺#相比，#iberdomide#在结合#Cereblon#中显示出更高的亲和力，可导致靶蛋白（包括转录因子 Ikaros 和Aiolos）强效降解，从而转化为更强效的抗#骨髓瘤#和免疫调节作用。

Lancet Haematol：Iberdomide治疗重度预处理多发性骨髓瘤结果，未来新治疗基石？

2023-03-26发表于上海

mswert122 (审核中...)

前往app查看评论内容

#骨髓瘤#骨髓瘤的进展非常迅速，好多大牛有讲座。

Post-ASCO 2020骨髓瘤的研究进展

2020-06-25

科室
- - 订阅+
  - 更多科室
工具
服务